We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.3B
AUM Growth
-$16.8M
Cap. Flow
-$266M
Cap. Flow %
-5.01%
Top 10 Hldgs %
22.18%
Holding
297
New
35
Increased
74
Reduced
86
Closed
35

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$60.5M
2
SPGI icon
S&P Global
SPGI
+$52.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$41.3M
4
AGN
Allergan plc
AGN
+$38.2M
5
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
+$37.2M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$98.3M
2
LLY icon
Eli Lilly
LLY
+$54.1M
3
AAPL icon
Apple
AAPL
+$51.2M
4
FIS icon
Fidelity National Information Services
FIS
+$42.9M
5
SYK icon
Stryker
SYK
+$40.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Financials 21.66%
3 Technology 21.39%
4 Communication Services 9.45%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNR icon
101
RenaissanceRe
RNR
$13.7B
$16.1M 0.3%
137,500
– –
RVNC
102
DELISTED
Revance Therapeutics, Inc.
RVNC
$15.9M 0.3%
1,168,542
-15,089
-1% -$267K
WRB icon
103
W.R. Berkley
WRB
$28B
$15.6M 0.29%
877,500
– –
GLOB icon
104
Globant
GLOB
$1.35B
$15.3M 0.29%
389,106
-62,221
-14% -$2.28M
BSX icon
105
Boston Scientific
BSX
$65.8B
$15.2M 0.29%
650,000
-413,081
-39% -$8.94M
POWI icon
106
Power Integrations
POWI
$3.54B
$14.7M 0.28%
+588,484
New +$14.4M
FIVN icon
107
FIVE9
FIVN
$1.77B
$14.5M 0.27%
+1,218,587
New +$12.4M
PRA
108
DELISTED
ProAssurance
PRA
$14.5M 0.27%
270,000
– –
TRV icon
109
Travelers Companies
TRV
$80.8B
$14.3M 0.27%
120,000
– –
AKAM icon
110
Akamai
AKAM
$16.8B
$14.1M 0.27%
252,736
+43,444
+21% +$2.29M
BRO icon
111
Brown & Brown
BRO
$22.9B
$14.1M 0.27%
750,000
– –
SIMO icon
112
Silicon Motion
SIMO
$9.19B
$14M 0.26%
292,963
-116,190
-28% -$4.88M
NBIX icon
113
Neurocrine Biosciences
NBIX
$17.7B
$13.5M 0.26%
298,036
+284,075
+2,035% +$13.1M
MBLY
114
DELISTED
Mobileye N.V.
MBLY
$13.4M 0.25%
290,783
-29,755
-9% -$1.14M
TXN icon
115
Texas Instruments
TXN
$255B
$13.4M 0.25%
213,457
-9,288
-4% -$552K
ANET icon
116
Arista Networks
ANET
$219B
$13.1M 0.25%
3,260,512
-1,700,608
-34% -$7.23M
BIDU icon
117
Baidu
BIDU
$35.8B
$12.5M 0.24%
75,600
-61,106
-45% -$10.7M
WTW icon
118
Willis Towers Watson
WTW
$27.9B
$12.4M 0.23%
100,000
+5,000
+5% +$617K
AWH
119
DELISTED
Allied World Assurance Co Hld Lt
AWH
$12.3M 0.23%
350,000
– –
AFL icon
120
Aflac
AFL
$63.9B
$12.3M 0.23%
340,000
– –
OSPN icon
121
OneSpan
OSPN
$562M
$12.2M 0.23%
746,186
+139,493
+23% +$2.32M
AXS icon
122
AXIS Capital
AXS
$8.59B
$12.1M 0.23%
220,000
– –
NVRO
123
DELISTED
NEVRO CORP.
NVRO
$12.1M 0.23%
+164,000
New +$11.1M
OXFD
124
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$12.1M 0.23%
1,340,871
+978
+0.1% +$9.58K
NEWR
125
DELISTED
New Relic, Inc.
NEWR
$11.4M 0.22%
+388,983
New +$10.7M
3 4
5
6 7

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Polar Capital held 297 positions worth $5.3B, down 0.32% from $5.32B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital withdrew a net $266M in Q2 2016, closing 35 positions and reducing 86 holdings. Its most notable exit was Stryker, an estimated $40.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Financials and Technology.

Against the trend, Polar Capital opened a new position in S&P Global worth $52.2M.

  • Polar Capital's largest Q2 2016 buy was S&P Global: 487,049 shares worth $52.2M.
  • Polar Capital added most to Pfizer in Q2 2016, an estimated $60.5M increase.
  • Polar Capital's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $98.3M.
  • Polar Capital fully exited Stryker in Q2 2016, selling an estimated $40.2M.
  • Polar Capital's ten largest holdings make up 22% of its $5.3B portfolio in Q2 2016.
  • Polar Capital opened 35 new positions and closed 35 in Q2 2016.
  • Polar Capital's portfolio value fell 0.32% quarter-over-quarter to $5.3B.

Based on Polar Capital's 13F filing for Q2 2016, filed 15 Aug 2016.